M Bala
Impact in
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Co-authors
- Josef S Smolen (2 shared papers)Joachim R. Kalden (2 shared papers)Ravinder N. Maini (2 shared papers)Cynthia Guzzo (4 shared papers)Chenglong Han (1 shared paper)Daniel E. Fürst (1 shared paper)D. van der Heijde (1 shared paper)F. C. Breedveld (1 shared paper)
- Journals
- British Journal of Dermatology (3 papers)Value in Health (3 papers)Inflammatory Bowel Diseases (2 papers)Dermatology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- TürkiyeUnited StatesNorway
In The Last Decade
M Bala
26 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 68
- Rheumatology 535
- Immunology 432
- Hematology 144
- Dermatology 111
- Biological Psychiatry 26
Countries citing papers authored by M Bala
This map shows the geographic impact of M Bala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Bala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Bala more than expected).
Fields of papers citing papers by M Bala
This network shows the impact of papers produced by M Bala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Bala. The network helps show where M Bala may publish in the future.
Co-authors
The 25 scholars most cited alongside M Bala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 365 | |
| 2 | 2008 | 186 | |
| 3 | 2008 | 151 | |
| 4 | 2006 | 116 | |
| 5 | 2005 | 115 | |
| 6 | 2008 | 80 | |
| 7 | 2022 | 10 | |
| 8 | 2016 | 9 | |
| 9 | Shorter hospital stays for angioplasty patients who receive abciximab. | 2000 | 7 |
| 10 | 2021 | 6 | |
| 11 | 2008 | 6 | |
| 12 | 2022 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2018 | 3 | |
| 16 | The effect of infliximab therapy on the prevention of new erosions in patients with early rheumatoid arthritis. | 2004 | 2 |
| 17 | 2016 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2006 | 2 | |
| 20 | 2021 | 2 |
About M Bala
M Bala is a scholar working on Surgery, Oncology, Epidemiology, Rheumatology and Genetics, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Shoulder Injury and Treatment (2 papers), Connective tissue disorders research (2 papers) and Shoulder and Clavicle Injuries (2 papers). The work is most often cited by research in Rheumatology (535 citations), Immunology (432 citations), Hematology (144 citations), Dermatology (111 citations) and Biological Psychiatry (26 citations). M Bala has collaborated with scholars based in Türkiye, United States and Norway. Frequent co-authors include Josef S Smolen, Joachim R. Kalden, Ravinder N. Maini, Cynthia Guzzo, Chenglong Han, Daniel E. Fürst, D. van der Heijde, F. C. Breedveld, Peter E. Lipsky and Ying Wu. Their work appears in journals such as British Journal of Dermatology, Value in Health, Inflammatory Bowel Diseases, Dermatology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.